Kidney involvement in the antiphospholipid syndrome

Journal of Autoimmunity

Volumn 15, Issue 2, 2000, Pages 127-132

  Nochy, Dominique ^a   Daugas, Eric ^a   Huong, Du Le Thi ^b   Piette, Jean Charles ^b   Hill, Gary ^a  

^a HÔPITAL BROUSSAIS   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE CLASSIFICATION; HISTOPATHOLOGY; HUMAN; KIDNEY BIOPSY; KIDNEY DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS;

EID: 0033834480     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2000.0423     Document Type: Conference Paper

References (33)

1. Thrombosis, abortion, cerebral disease and lupus anticoagulant
2. The anticardiolipin syndrome
3. Thrombosis, recurrent fetal loss and thrombocytopenia: Predictive value of the anticardiolipin antibody test
4. The antiphospholipid syndrome: A syndrome in evolution
5. Glomerular thrombosis in systemic lupus erythematosus: Prevalence and significance
6. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants
7. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: A prospective analysis of 500 consecutive patients
8. Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematous (SLE) patients and non-SLE disorders
9. Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy-related renal failure
10. Renal manifestations in the antiphospholipid syndrome
11. Primary antiphospholipid syndrome with multiorgan arterial and venous thrombosis
12. Catastrophic antiphospholipid syndrome: Clinical and laboratory features of 50 patients
13. The intrarenal vascular lesions associated with primary antiphospholipid syndrome
14. Systemic and renal fibrinolytic activity in a patient with anticardiolipin syndrome and renal thrombotic microangiopathy
15. Renal involvement in primary antiphospholipid syndrome
16. Acute renal failure as first clinical manifestation of the primary antiphospholipid syndrome
17. Reversible renal failure in the primary antiphospholipid syndrome. A report of two cases
18. Renal microangiopathy in the primary antiphospholipid syndrome: A case report with literature review
19. Anticardiolipin antibody and renal disease: A report of three cases
20. Abnormalities of renin-containing cells in human glomerular and vascular renal diseases
21. Renal vascular disease in patients with primary antiphospholipid antibodies
22. Recurrent thrombosis and renal vascular disease in patients with a lupus anticoagulant
23. Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome
24. Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis
25. Lupus anticoagulant in systemic lupus erythematosus. A clinical and renal pathological study
26. Malignant hypertension in antiphospholipid syndrome without overt lupus nephritis
27. Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome
28. In SLE, is there antiphospholipid nephropathy separable from lupus nephritis?
29. Significance of antiphospholipid antibodies in patients with lupus nephritis
30. Systemic lupus erythematosus: Clinical and immunologic patterns of disease expression in a cohort of 1,000 patients
31. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies
32. Relationship of lupus anticoagulant, anticardiolipin, anti beta-2-GPI and anti-prothrombin autoantibodies with history of thrombosis in patients with the clinical suspicion of APA-syndrome
33. Insidious loss of renal function in patients with anticardiolipin antibodies and absence of overt nephritis